• Salona Global Medical Device Corporation (SGMD) has announced a bought-deal private placement for gross proceeds of $4,004,000
  • The company will issue 7,280,000 units at a price of $0.55 per unit
  • Salona has also provided the underwriters with an over-allotment option for additional gross proceeds of up to $600,600
  • The offering is expected to close on or about February 15, 2022
  • Salona Global Medical Device Corp is a U.S.-based medical device company
  • Salona Global Medical Device Corporation (SGMD) opened trading at C$0.55 per share

Salona Global Medical Device Corporation (SGMD) has announced a bought-deal private placement for gross proceeds of $4,004,000.

The company will issue 7,280,000 units at a price of $0.55 per unit. Each unit will consist of one common share and one share purchase warrant. Each warrant can be exercised for one additional share at a price of $0.70 for up to three years following the closing of the offering.

Salona has also provided the underwriters with the option to purchase up to an additional 1,092,000 units, for additional gross proceeds of up to $600,600.

Net proceeds will be used for working capital and general corporate purposes.

The offering is expected to close on or about February 15, 2022.

Salona Global Medical Device Corp is a U.S.-based medical device company. 

Salona Global Medical Device Corporation (SGMD) opened trading at C$0.55 per share.

More From The Market Online

Cannabix delivers marijuana breath test to Eastern Canada workplace testing clinic

Cannabix Technologies (CSE:BLO) delivered its Marijuana Breath Test devices to a workplace drug and alcohol testing clinic in eastern Canada.

Biotech company patenting world’s first AI voice test for substance abuse

Biotech company MindBio files a patent application for the world's first AI model to detect substance abuse though vocal analysis.

2 biotech stocks bridging the gap between unmet need and next-gen medicine

Exploring Lunai Bioworks and TheraCryf, two biotech stocks taking early strides towards improving the lives of tens of millions of patients.